Table 2.
Relationship between the number of risk factors according to mUS and the presence of non-OC disease.
| Risk factors | Patients, n (%) |
p value* | |
|---|---|---|---|
| OC disease | Non-OC disease | ||
| 0 | 24 (88.9) | 3 (11.1) | <0.001 |
| 1 | 4 (40.0) | 6 (60.0) | |
| 2 | 1 (14.3) | 6 (85.7) | |
| 3 | 0 (0) | 4 (100) | |
| 4 | 1 (20.0) | 4 (80.0) | |
| 5 | 0 (0) | 1 (100) | |
| mUS-based assessment for non-OC diseasea | |||
| 0 | 24 (88.9) | 3 (11.1) | <0.001 |
| ≥1 | 6 (22.2) | 21 (77.8) | |
CI = confidence interval; mUS = micro-ultrasound; OC = organ confined.
a
Diagnostic performance of mUS-based assessment of non-OC disease: sensitivity 87.5% (95% CI 74.3–100.0%), specificity 80.0% (95% CI 65.7–94.3%); negative predictive value 88.9% (95% CI 77.1–100%), and positive predictive value 77.8% (95% CI 62.2–93.4%).
*
χ2 test.